Wealthfront Advisers LLC Takes Position in agilon health, inc. (NYSE:AGL)

Wealthfront Advisers LLC acquired a new position in shares of agilon health, inc. (NYSE:AGL) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 26,686 shares of the company’s stock, valued at approximately $51,000.

Other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the period. Inspire Investing LLC grew its stake in shares of agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after purchasing an additional 112,241 shares during the period. Citigroup Inc. grew its stake in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares during the period. Geode Capital Management LLC grew its stake in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after purchasing an additional 84,889 shares during the period. Finally, Empowered Funds LLC acquired a new stake in shares of agilon health during the fourth quarter worth $97,000.

Wall Street Analyst Weigh In

AGL has been the subject of a number of analyst reports. Royal Bank of Canada lifted their price objective on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein lifted their price objective on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Wednesday, February 26th. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Finally, Macquarie initiated coverage on agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Up 3.2 %

AGL stock opened at $4.34 on Wednesday. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The stock has a market capitalization of $1.79 billion, a P/E ratio of -4.61 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The business has a 50-day moving average of $3.39 and a 200-day moving average of $2.93.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.